# Bloomage Biotechnology

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/bloomage-biotechnology
Canonical HTML page: https://getbiobrief.com/entity/bloomage-biotechnology

## Timeline

- **2026-03-21**: Annual Results Announcement — Official report confirms a retreat in full-year net income compared to the previous fiscal year.
- **2025-11-20**: VBP Participation — Company participates in multi-province centralized procurement for intraocular lenses, securing volume at lower price points.
- **2025-06-15**: Aesthetics Expansion — Haohai launches new line of high-end dermal fillers to compete in the premium aesthetics market.

## Recent coverage (1 stories)

### Haohai Biological Reports Full-Year Income Retreat Amid VBP Pressures
2026-03-21 04:50:54 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Shanghai Haohai Biological Technology Co., Ltd. has reported a decline in full-year income for the 2025 fiscal year, driven by margin compression in its core ophthalmology and orthopedic segments. The retreat highlights the ongoing challenges of China's volume-based procurement (VBP) policies and intensifying competition in the medical aesthetics market.
Full story: https://getbiobrief.com/story/haohai-biological-full-year-earnings-retreat-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.